Dosidal · Switzerland

Rivaroxaban Sandoz vascular, Filmtabletten

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:68804 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 68804
atc: B01AF01
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2022-10-10
term: zugelassen
valid_until: 2027-10-09
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: B01AF01
authorisation_number: 68804
form: FILM
holder: Sandoz Pharmaceuticals AG
holder_partner_nr: 1006431
it_number: 06.03.0.
name: Rivaroxaban Sandoz vascular, Filmtabletten
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
qjEz76EET3SEihLLwM8io-Kl7N-QYjHJdkftcFm7jeAxBfuJ4L8oIBW0Q--Glt58PlaUZlVklHISNyrS_I3P4Q
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:68804 · Related records in other markets · Dosidal